Loading
Latest filing published 04 Sept 2026 for Addex Therapeutics Ltd..
No signal scores available.
Vincent Michael Lawton discloses dealings in Addex Therapeutics Ltd. to SEC (Form 4). We count 2 filings, every one of them for a trade on 2 September 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 4 September 2026, the filings show a transaction in Addex Therapeutics Ltd. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations